Tuesday, 22 October 2019

Dr. Reddy's launches Daptomycin for Injection

15 May 2019 | News

Daptomycin, Injection, vials, Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. announced the launch of Daptomycin for Injection, 500mg/vial single-dose vial, a therapeutic equivalent generic version of Cubicin® for Injection, approved by the U.S. Food and Drug Administration (USFDA).  

The Cubicin® for Injection (daptomycin for injection) brand and generic had U.S. sales of approximately $640.8 million MAT for the most recent twelve months ending in March 2019 according to IQVIA Health. 

Dr. Reddy’s Daptomycin for Injection is available in single-dose 15 ml vials containing 500 mg of daptomycin.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account